Vimarsana
Biggest News Aggregation in the World

John Glasspool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Glasspool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Glasspool Today - Breaking & Trending Today

Study Confirming Overwhelming Reduction in Bleeding of the Dual-Acting Factor XI/XIa Inhibitor Abelacimab as Compared to Rivaroxaban Selected as Late-Breaker Oral Presentation at the American Heart Association Scientific Sessions - Vimarsana News

Study Confirming Overwhelming Reduction in Bleeding of the Dual-Acting Factor XI/XIa Inhibitor Abelacimab as Compared to Rivaroxaban Selected as Late-Breaker Oral Presentation at the American Heart Association Scientific Sessions

Study participants may transition from the rivaroxaban arm to abelacimab in an extension study 

Letter to the editor: Forecourt diesel prices, -'rip-off Romsey'? - Vimarsana News

Letter to the editor: Forecourt diesel prices, -'rip-off Romsey'?

Two weeks ago I had to go to Andover, where I was amazed to see that diesel cost around £1.42 per litre.

'Thieving couple steal cash' from village church donation box - as police 'too busy' to pursue it - Vimarsana News

'Thieving couple steal cash' from village church donation box - as police 'too busy' to pursue it

A Hampshire parish councillor claims to have caught a pair of donation box robbers on church CCTV - after police said they were 'too busy' to investigate.

Anthos Therapeutics to Host Discussion with Global Experts on the Promise of Factor XI Inhibition at the 2022 BIO International Convention - Vimarsana News

Anthos Therapeutics to Host Discussion with Global Experts on the Promise of Factor XI Inhibition at the 2022 BIO International Convention

CAMBRIDGE, Mass., June 13, 2022 /PRNewswire/ -- Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ca...

02.09.22 -- Pod Lovers: Hybrid mAb Manufacturing, RNA's Advantages Over Other Cell Therapies and more! - Vimarsana News

02.09.22 -- Pod Lovers: Hybrid mAb Manufacturing, RNA's Advantages Over Other Cell Therapies and more!

02/09/22 Life Science Leader Newsletter